By annette
A newly publishes study from IHE, based on Swedish register data, indicate that people with GPP have more sick leave than both the general population and people with psoriasis vulgaris.
By annette
The Swedish Institute for Health Economics (IHE) and the Bengt Jönsson Foundation for Health Economics Research are hereby pleased to announce the recipient of the scholarship for this year’s student thesis in health economics. Recipients of this year’s scholarship are Ida Haggren and Lucas Henriksson for their thesis ”European Tobacco Taxation and Youth Smoking – Findings …
By annette
IHE’s Andrea Manzano presented at the Simposio Oncolatino, a pan-Latin American conference about cancer. She delivered a presentation about the key findings of IHE Report 2023:6 on ‘Improving outcomes for women with triple-negative breast cancer in Latin America’. Conference link: https://oncolatino.org/ Link to IHE Report: https://ihe.se/rapport/improving-outcomes-for-women-with-triple-negative-breast-cancer-in-latin-america/ Name of conference/poster/other: Simposio Oncolatino Place: Mexico City, Mexico …
By annette
This study examines access to novel cancer medicines in four countries in Central and Eastern Europe – Czechia, Hungary, Poland, Slovakia – in relation to clinical benefit. Read more
By annette
A new study by IHE in Value in Health Regional Issues estimates the disease burden and economic burden of cancer in the Middle East and Africa. Read more
By annette
The Swedish Institute for Health Economics welcomes Hedda Carlsson and Bardh Manxhuka who joined our team in June and they both work as research analyst at the Lund office.
By annette
On June 8th, IHE’s Thomas Hofmarcher participated in a webinar organized by the Financial Times to mark the official launch of IHE Report 2023:2. The report shows that triple-negative breast cancer (TNBC) is the most difficult-to-treat subtype of breast cancer. It accounts for about 10–20% of newly diagnosed breast cancer cases but is responsible for …
By annette
We are happy to announce that Jenni Nordborg – Director of International Affairs at Lif – The research-based pharmaceutical industri – joins our Board of Directors Read more about Jenni Nordborg
By annette
In this IHE report the author Ulf Persson, senior advisor at IHE, has identified a number of conditions which lead to the fact that today’s methods of valuing medicines hardly lead us to a satisfactory understanding of the value of orphan medicines. The insurance value, the value of hope and process-related benefits are not included. …
By annette
Michael Willis from IHE will participate in two workshops at SMDM-Society for Medical Decision Making, May 21-23 in Berlin. Issue Panel 1C: Proving health economics models are valid – why, how and who? Chair: Talitha Feenstra (National Institute for Public Health and the Environment (RIVM), Netherlands) Panelists: Amanda Adler, University of Oxford, UK Xavier Pouwels, …